These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 25216866)
1. Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma. Qu X; Zhao M; Wu S; Yu W; Xu J; Xu J; Li J; Chen L Med Oncol; 2014 Oct; 31(10):219. PubMed ID: 25216866 [TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Li J; Zhang M; Wang C J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in urine as diagnostic biomarkers for multiple myeloma. Li J; Wang C; Meng Q; Hu Z; Hu M; Zhang M Int J Lab Hematol; 2021 Apr; 43(2):227-234. PubMed ID: 33068078 [TBL] [Abstract][Full Text] [Related]
4. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
5. The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma. Jiang Y; Luan Y; Chang H; Chen G Oncol Lett; 2018 Sep; 16(3):4001-4007. PubMed ID: 30128020 [TBL] [Abstract][Full Text] [Related]
6. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis. Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627 [TBL] [Abstract][Full Text] [Related]
7. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
8. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390 [TBL] [Abstract][Full Text] [Related]
9. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture. Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261 [TBL] [Abstract][Full Text] [Related]
10. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma. Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis. Murata K; Furu M; Yoshitomi H; Ishikawa M; Shibuya H; Hashimoto M; Imura Y; Fujii T; Ito H; Mimori T; Matsuda S PLoS One; 2013; 8(7):e69118. PubMed ID: 23874885 [TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction. Wang F; Long G; Zhao C; Li H; Chaugai S; Wang Y; Chen C; Wang DW PLoS One; 2014; 9(9):e105734. PubMed ID: 25184815 [TBL] [Abstract][Full Text] [Related]
13. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Wang M; Gu H; Wang S; Qian H; Zhu W; Zhang L; Zhao C; Tao Y; Xu W Mol Med Rep; 2012 Jun; 5(6):1514-20. PubMed ID: 22406928 [TBL] [Abstract][Full Text] [Related]
14. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer. Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708 [TBL] [Abstract][Full Text] [Related]
15. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718 [TBL] [Abstract][Full Text] [Related]
17. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma. Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540 [TBL] [Abstract][Full Text] [Related]
18. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy. Ji H; Yi Q; Chen L; Wong L; Liu Y; Xu G; Zhao J; Huang T; Li B; Yang Y; Li W; Han L; Duan S Clin Chim Acta; 2020 Feb; 501():147-153. PubMed ID: 31678272 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540 [TBL] [Abstract][Full Text] [Related]
20. Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction. Yao XL; Lu XL; Yan CY; Wan QL; Cheng GC; Li YM Int J Clin Exp Pathol; 2015; 8(12):16014-9. PubMed ID: 26884877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]